Perspectives and challenges of clinical pharmacogenomics in cancer

Pharmacogenomics

Volumn 5, Issue 5, 2004, Pages 451-454

  Pusztai, Lajos ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; TRASTUZUMAB; TUMOR MARKER;

BREAST CANCER; CANCER DIAGNOSIS; CANCER GENETICS; CANCER TISSUE; CLINICAL LABORATORY; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG APPROVAL; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION PROFILING; GENOMICS; HUMAN; MEDICAL DECISION MAKING; MEDICAL INSTRUMENTATION; PATIENT SELECTION; PHARMACOGENOMICS; PREDICTION; PROGNOSIS; PROTEOMICS; QUALITY OF LIFE; SIDE EFFECT; VALIDATION PROCESS;

CLINICAL TRIALS; HUMANS; NEOPLASMS; PHARMACOGENETICS; TUMOR MARKERS, BIOLOGICAL;

EID: 3543094382     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.5.5.451     Document Type: Editorial

References (8)

1. Bast RC Jr, Ravdin P, Hayes DF et al.: American Society of Clinical Oncology Tumor Markers Expert Panel. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 19, 1865-1878 (2001).
2. Ross JS, Linette GP, Stec J et al.: Breast cancer biomarkers and molecular medicine. Expert Rev. Mol. Diagn. 3(5), 573-585, (2003).
3. Ross JS, Linette GP, Stec J et al.: Breast cancer biomarkers and molecular medicine: part II. Expert Rev. Mol. Diagn. 4(2), 169-188 (2004).
4. van de Vijver MJ, He YD, van't Veer LJ et al.: A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347(25), 1999-2009 (2002).
5. Ayers M, Symmans WF, Stec J et al.: Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel/FAC chemotherapy in breast cancer. J. Clin. Oncol. 22(12), 2284-2293 (2004).
6. Lossos IS, Czerwinski DK, Alizadeh AA et al.: Prediction of survival in diffuse large B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 350(18), 1828-1837 (2004).
7. Wang Y, Jatkoe T, Zhang Y et al.: Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J. Clin. Oncol. 22(9), 1564-1571 (2004).
8. Paik S, Shak S, Tang G et al.: Multi-gene RT-PCR assay for predicting recurrence in node negative breast cancer patients - NSABP studies B-20 and B-14. Breast Cancer Res. Treat. 82(Suppl. 1), S10 (2003) (Abstract 16).